Cardiopulmonary and Circulatory Interactions During Gravity Trasnsitions in Parabolic Flight - Joint Approach of Gravitational Physiology and Anaesthesiology  - by Limper, Ulrich
 
 
 
Lehrstuhl für Anästhesiologie II der Universität Witten/Herdecke 
 
 
 
Cardiopulmonary and Circulatory Interactions During Gravity Transitions in Parabolic Flight 
- Joint Approach of Gravitational Physiology and Anaesthesiology - 
 
 
 
Inaugural Dissertation 
Zur 
Erlangung des Grades eines Doktors der Medizin 
der Universität Witten/Herdecke 
Fakultät für Gesundheit 
 
 
 
 
 
 
 
Vorgelegt von Klaus Ulrich Limper 
aus Bergisch Gladbach 
2014  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dekan: Herr Prof. Dr. med. Stefan Wirth 
Mentor: Herr Prof. Dr. med. Frank Wappler 
Externer Mentor: Herr Dr. Luis. E. J. Beck 
Zweitgutachter: Herr PD Dr. med. Christian Weinand 
Externer Gutachter: Herr Prof. Dr. med. Alexander Choukèr 
Tag der Disputation: 25. Februar 2015 
 
 
 
 
 
 
 
 
 
 
 
 
 
Meinen Eltern und meiner Großmutter gewidmet 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 5 
Contents 
Preface ............................................................................................................................................................. 7 
Chapter One .................................................................................................................................................. 11 
1  General introduction and outline of this thesis ................................................................................. 11 
1.1  The physiology of the human body under gravitational stress .............................................. 11 
1.1.1  Human orthostatic control .................................................................................................... 11 
1.1.2  The lungs under gravitational stress .................................................................................. 13 
1.1.3  Human cardiovascular control in parabolic flight ............................................................. 14 
1.1.4  The heart in parabolic flight ................................................................................................. 17 
1.1.5  The central venous blood pressure in parabolic flight and in space ............................. 18 
1.1.6  Interactions of the cardiovascular, vestibular, visual and the postural systems ......... 19 
1.2  Methods .......................................................................................................................................... 20 
1.2.1  The parabolic flight ............................................................................................................... 20 
1.2.2  Design of a European parabolic flight campaign ............................................................. 21 
1.2.3  The flight trajectory ............................................................................................................... 22 
1.2.4  The airplane ........................................................................................................................... 22 
1.2.5  The cabin atmosphere ......................................................................................................... 23 
1.2.6  Flight medication ................................................................................................................... 24 
1.2.7  Medical considerations of parabolic flights ....................................................................... 25 
1.3  Ground-based facilities and measurement techniques ........................................................... 25 
1.3.1  The hypobaric chamber at the DLR ................................................................................... 25 
1.3.2  Blood volume determination by carbon monoxide rebreathing (CORB) ...................... 26 
1.3.3  Biochemical analyses of parabolic flight and hypobaric chamber blood samples ...... 27 
1.3.4  Cardiac output determination via inert gas rebreathing .................................................. 27 
1.3.5  Cardiac output determination via impedance cardiography ........................................... 28 
1.3.6  Cardiac output determination via pulse contour analysis ............................................... 30 
Chapter Two .................................................................................................................................................. 37 
Upright Cardiac Output Measurements in the Transition to Weightlessness during Parabolic 
Flights (Aviation, Space, and Environmental Medicine 2011; 82(4):448-454) ................................ 37 
Chapter Three ............................................................................................................................................... 47 
Pulse contour methods to estimate cardiovascular indices  in micro- and hypergravity (Aviation, 
Space, and Environmental Medicine 2013; 84(11):1178-1185) ........................................................ 47 
Chapter Four ................................................................................................................................................. 57 
Interactions of the human cardiopulmonary, hormonal and body fluid systems in parabolic flight 
(European Journal of Applied Physiology 2014; 114(6):1281-1295) ................................................ 57 
6 
Appendix .................................................................................................................................................... 75 
Chapter Five .................................................................................................................................................. 77 
5  Final considerations and clinical implications ................................................................................... 77 
5.1  Cardiac output determination in non-steady state cardiovascular conditions ..................... 77 
5.2  Behavior of cardiac output as the key variable of the circulation during intense orthostatic 
and anti-orthostatic stress in parabolic flight ........................................................................................ 79 
5.3  Response of the pulmonary circulation to orthostatic and anti-orthostatic stress in a 
moderately hypobaric hypoxic environment ......................................................................................... 80 
5.4  How the human body fluid and endocrine systems respond to a combination of moderate 
hypobaric hypoxia and gravity changes ................................................................................................ 82 
5.5  Outlook ........................................................................................................................................... 82 
Summary ........................................................................................................................................................ 87 
Zusammenfassung ....................................................................................................................................... 88 
Abbreviations ................................................................................................................................................. 89 
Declaration of funding and conflict of interests ........................................................................................ 90 
Curriculum Vitae............................................................................................................................................ 91 
List of publications ........................................................................................................................................ 92 
Danksagung ................................................................................................................................................... 93 
Eidesstattliche Erklärung ............................................................................................................................. 94 
 7 
Preface 
You are an anesthesiologist; why do you perform experiments in space flight-related conditions? 
What is the benefit of research in those extreme environments for humans on Earth? I have been 
asked these excellent questions repeatedly. To answer these questions and to justify the research 
of this thesis, I have to go into greater detail. First, I would like to underpin the development of the 
anesthetist from a pure anesthesia provider to a qualified perioperative physician (1) who takes 
care of the patient receiving major surgery during all phases of his hospital stay. This development 
requires a detailed and global understanding of human physiology and pathophysiology not only in 
the context of the operation theatre but also in the context of pre-anesthesia care and post-surgical 
intensive care medicine. Fortunately, the anesthetist works under particular and unique conditions 
that allow him to observe many of the physiological key reactions of the human body. This work is 
possible because an anesthetist routinely handles inotropic drugs and fluids and provides artificial 
ventilation, enabling him to immediately follow the responses of the patient’s body during these 
interventions. This ability makes the anesthetist an experienced applied integrative physiologist 
and patho-physiologist and makes him interested in applied physiological research. Furthermore, 
an anesthetist becomes aware of numerous physiological and operational questions and issues 
during his daily work, e.g., what is normovolemia, how is cardiac output regulated, and how can I 
measure cardiac output invasively and, even better, non-invasively? It seems intuitive to answer 
these questions directly in the situations in which they arise, meaning in patients receiving 
anesthesia or intensive care. However, the cardiovascular system of individuals in these situations 
is maintained at a steady state by the carefully treating anesthetist. Thus, for a better 
understanding of human cardiovascular physiology and of the reliability and validity of 
cardiovascular monitoring methods, it is helpful to investigate the human cardiovascular system 
under environmental conditions, pushing the system to its limits, e.g., high or low gravity, cold, heat 
or hypoxia. 
The field of research of this thesis is “Extreme Environment Physiology”, which is a part of the 
“Integrative Physiology” approach (2). This area of physiological research integrates research, 
among others, in high altitude, in space flight, in high performance flight, during high performance 
tasks, in confinement, in cold and heat and in diving. In these environments, the ambient 
conditions are challenging and in some cases even hostile for the human body and include 
hypobaric hypoxia, hyperbaric pressure, weightlessness and hypergravity, isolation, other types of 
psychological stress and extreme temperatures. Extreme environmental physiology tries to 
determine the impact of those environments and stressors on the human body, each stress on its 
own or in combination with others (3). Many of our physiological systems are affected by extreme 
environments: the cardiovascular system; the lungs; the kidneys and the fluid regulation system; 
the brain, bones and muscles; the immune system; and the blood coagulation system. Challenging 
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our human physiological systems by exposing them to extreme environmental conditions not only 
allows us to learn how these systems work under these particular conditions, but extreme 
environments can serve as a reasonable model for aging and for several diseases. Astronauts on 
long-term space missions aboard the International Space Station (ISS), for example, suffer from a 
loss of bone and skeletal muscle mass (4) and from cardiac atrophy (5), which allowed scientists 
some decades ago to use astronauts during and after spaceflight as a model for the process of 
aging of the human body. Furthermore, many astronauts suffer from circulatory weakness and pre-
syncopes, known as postflight orthostatic intolerance (POI), when they return to Earth. That is why 
astronauts are used as an in vivo model to better understand dysautonomias (6), which can be 
observed in patients suffering from Parkinson’s disease, diabetes mellitus, spinal cord injury or 
from severe brain trauma and which play a significant role in the work of an anesthetist (7). Again, 
astronauts show a decreased arterial blood pressure in space although their sympathetic nervous 
system is up-regulated at the same time (8), leading to the paradox of systemic vasodilatation and 
sympathetic nervous stimulation in space (9). The anesthetist faces a similar paradox in patients 
suffering from liver cirrhosis and from hepatorenal syndrome, which combines systemic 
vasodilatation and increased systemic and renal sympathetic tone with renal vascular constriction 
(10, 11).  
Therefore, many research projects have been performed by anesthetists in extreme environments 
to better understand the patho-physiology of critically ill patients starting from Mount Everest (12, 
13), the Capanna Margherita in the Suisse Alps (14) and Antarctica (15) to the International Space 
Station (16) and parabolic flights (17, 18). On the other hand, many of the results of space flight-
related research performed by non-anesthetists have become influential for anesthesiology. The 
surprising behavior of the central venous pressure (CVP) in space, which is lower in 
weightlessness than on the ground despite the central blood volume shift in space, make it clear 
that CVP is far from understood (19). A complete understanding of CVP and of its value for 
anesthesiology is still lacking. A further physiological concept according to J. West with importance 
for anesthesiology is the zoning of the perfusion of the lungs into three sections depending on 
gravity (20). Parabolic flights, among other scientific approaches, provided the unique environment 
to show that the West concept is not telling the full story and that gravity seems not to be the main 
factor regarding blood flow distribution in the lungs. In fact, the structure of the pulmonary vascular 
tree itself seems to be the primary determinant of regional lung perfusion (21). A final example 
benefitting anesthesia care that emerged from space flight-related research is a new 
understanding of sodium physiology. The classical concept of sodium and body fluid regulation 
tells us that sodium is osmotically active and therefore that sodium and body fluid regulation are 
always linked. From space flight experiments, however, we know that sodium can also be stored 
osmotically inactivated in tissues, and that sodium homeostasis is linked to the immune system. 
The great number of critically ill patients suffering from a coupling of dysnatremia and immune 
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system dysregulation (22, 23) makes it clear that this new mechanism of sodium and fluid 
regulation in humans may gain importance for the treatment of the critically ill. 
In addition to the symbiosis of anesthesiology and extreme environment physiology in the context 
of joint (patho-) physiological research hypotheses, there is also an interdisciplinary affinity within 
the meaning of joint medical-technical challenges. After the era of the American space shuttle, with 
its short space flight missions lasting no longer than two weeks and undertaking mainly research 
missions, the era of the International Space Station (ISS), with its long-duration space missions, 
appeared. A new medical issue emerged, namely the need to protect the astronauts’ health 
against the deconditioning of the physiological systems as triggered by chronic weightlessness. 
Thus, astronaut health monitoring has gained importance. The challenges of astronaut health 
monitoring, e.g., of the cardiovascular system, became clear considering the extreme environment 
of the ISS. Due to a lack of medical support in this isolated place, monitoring techniques should be 
safe, non-invasive, reliable and easy to handle. These requirements make non-invasive finger 
blood pressure measurement, impedance cardiography and inert gas re-breathing techniques the 
methods of choice. However, these methods perform best only when the cardiovascular system is 
in a so-called steady state, which is not the case during the most important phases of a space flight 
mission, i.e., the launch and transition into weightlessness; the early phase in weightlessness; the 
reentry; and the hours after landing. Establishing high-performing, non-invasive methods of 
cardiovascular monitoring in clinical practice is therefore a common goal in space medicine and in 
anesthesiology and intensive care medicine. However, methods such as non-invasive pulse 
contour analysis and impedance cardiography have failed to demonstrate their reliability in 
unstable individuals, such as sepsis or trauma patients.  
Returning to the introductory question of this preamble, it makes sense to look ahead as well. 
Although a future manned flight to Mars or to near-earth asteroids seems to be far away at this 
stage and although access to the ISS is limited to only a few highly trained astronauts, a 
fundamental investigation of the human physiological systems is mandatory for long-duration 
space missions and for the future exploration of other orbs. Thus, anesthetists, among physicians 
from other disciplines, are eligible and predestined to perform such research because of their deep 
understanding of applied physiology. 
In conclusion, this thesis tends to increase knowledge of the human cardiovascular system and 
about the performance of non-invasive cardiovascular monitoring methods under severe 
cardiovascular stress. This thesis tends furthermore to transfer this knowledge from the space 
flight-related field into the applied field of anesthesiology and intensive care medicine.  
 
Cologne, September 2014 
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Chapter One 
1 General introduction and outline of this thesis 
This thesis addresses the cardiovascular system under alternating gravitational stress and how to 
measure cardiovascular indices noninvasively in this particular environment. Gravitational stress 
and dynamic exercise require probably the most complex control mechanisms of our 
cardiovascular system; therefore, investigating the circulation under these circumstances provides 
the greatest insight into the way this system works. Thus, this thesis uses the former stress to gain 
new insight into the human cardiovascular system. 
1.1 The physiology of the human body under gravitational stress 
1.1.1 Human orthostatic control 
The human cardiovascular system is not well equipped to perform in upright posture under the 
influence of the gravity of our planet Earth. The physiologist L. Rowell put it in a nutshell in his book 
Cardiovascular Control when he wrote the following: “The human circulation was not well 
“designed” for being positioned upright with its pump high above a system of compliant tubes, 
which are highly susceptible to effects of gravity” (1). That our brain is provided with adequate 
blood perfusion in almost any body position however demonstrates that evolution generated 
efficient countermeasures to fight against the trend of the blood to shift away from the brain to the 
dependent parts of our upright body. However, an understanding in greater detail of the human 
cardiovascular system under gravitational stress is mandatory to understand the results of this 
thesis. Gravity is omnipresent and acts continuously on the human body everywhere on the planet 
Earth. Most quadrupeds, e.g. dogs, withstand gravity well while they stand on their four feet 
because approximately 70% of their blood volume is arranged at or above their hearts, which again 
try to pump it to their brains. Thus, venous return to the heart is well maintained when quadrupeds 
walk on their four feet. However, when our ancestors increased their bodies and developed the 
ability to stand and to walk upright on two feet, also referred to as orthostasis, gravity became a 
real threat for the human body because, in an upright body position, it pulls blood away from the 
heart and the brain toward the dependent parts of the body, such as the legs and the splanchnic 
vascular beds (fig. 1.1). Orthostatic blood pooling in the splanchnic system in particular is often 
neglected in orthostatic research, although approximately 25% of the human blood volume is 
stored in the viscera, which are therefore important blood reservoirs (2). Two thirds of this blood 
volume can be autotransfused into the systemic circulation within seconds. This autotransfusion 
works because sympatoadrenal stimulation leads to active splanchnic venoconstriction via alpha-
adrenoceptors (2). Again, in an upright stance, the venous return of blood to the heart drops and 
cardiac output and brain perfusion thereby decrease. Without the physiological countermeasures 
of the cardiovascular system, so-called orthostatic reflexes, humans would faint in an upright body 
position. In the upright human body, 70% of the blood volume is situated below the heart level. 
General introduction and outline of this thesis 
12 
This downward blood volume shift opposes the efforts of the human heart to pump blood up to the 
brain, which sits in an upright body position approximately 30 cm above the heart. The driving force 
of this downward blood volume shift is the hydrostatic pressure of the blood column together with 
the fact that the veins of the human body are compliant and not made out of resistant tubes that 
could withstand the hydrostatic pressure of the blood column in standing position. 
 
Figure 1.1: Comparative presentation of the (biped) human body and the body of a quadruped under 
gravitational stress. The blood volume distribution in the human body in the supine position is similar to that 
of a quadruped walking on its four feet. Standing on two feet induces a downward blood volume shift in both 
the human and the quadruped body, making orthostatic hypotension likely in both creatures. Adapted from 
(3). 
Therefore, approximately 75% of the blood volume is in those compliant veins. The hydrostatic 
pressure of a fluid column, similar to the blood in the vascular system, refers to ρ • g • h, where p is 
the fluid density, g is the acceleration due to gravity, and h is the height of the hydrostatic column. 
This formula clearly shows that the hydrostatic pressure of a fluid column is correlated with 
acceleration due to gravity. If acceleration is doubled, the hydrostatic pressure is doubled 
correspondingly, and if acceleration becomes zero, the hydrostatic pressure becomes zero as well. 
Therefore, the blood volume shift from the thorax to the dependent parts of our body is greater in 
hypergravity than in normo-gravity and does not exist in weightlessness. Thus, when a human 
stands up under 1 Gz, 500 to 1000 ml of blood drains off the thorax into the lower parts of the body 
(4). This drainage suggests that venous return is one of the main if not the most important variable 
during orthostatic stress. Without potent countermeasures, our body would develop presyncope or 
syncope immediately after rising. The body fights orthostatic intolerance through two main 
mechanisms. The first mechanism is the baroreceptor reflex, briefly baroreflex. The arterial 
baroreceptors are so-called high pressure receptors that are located in the carotid arteries and in 
the aortic arch. In the supine position, these receptors sense the same mean arterial pressure as 
that at the level of the heart. When the human body is raised, the baroreceptors are suddenly 
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located 10-20 cm above the level of the heart. Due to the changed hydrostatic pressure at the 
baroreceptor side and to a decreasing cardiac output, the mean arterial pressure at the level of the 
baroreceptors drops by 10-15 mmHg after standing up. The baroreceptors now send a changed 
neuronal signal to the brain stem, which leads to a depression of the vagal nerve at the heart and 
to an activation of the sympathetic innervation of the heart and of the resistance vessels. This 
modulation of the autonomic innervation of the heart and the vessels leads to an increased heart 
rate and inotropy and to arterial and venous vasoconstriction. Thus, cardiac preload, afterload and 
force increase. To further recover the dropped venous return or rather the preload of the heart, the 
body activates the muscle and respiratory pumps.  
  
Figure 1.2: The central volume shift and the particular changes of the hydrostatic pressure in weightlessness 
are shown with respect to the standing human body in 1 Gz. MVP (mmHg), mean venous pressure; MAP 
(mmHg), mean arterial pressure. The formula for hydrostatic pressure is given as P=ρ*g*∆h. P, pressure 
(kPa); ρ, volumetric mass density (kg*m-3); g, Earth gravity (m*s-2); ∆h,  height of the hydrostatic column (m). 
Adapted from (5). 
1.1.2 The lungs under gravitational stress 
The lungs are a blood reservoir that plays an important role in human orthostasis (6). In addition, 
the lungs function as the central gas exchange organ of the human body. In this thesis, the lungs 
play a particular role as the key organ for cardiac output determination by the inert gas rebreathing 
method. Therefore, the impact of hyper- and microgravity on the lungs seems to be important, and 
it is clear that gravity influences the blood flow distribution and the ventilation of the lungs. The 
lungs contain approximately 300 ml of blood, of which 25% is in the pulmonary capillaries (7). The 
classical concept that describes a dependency on gravity of the lungs’ blood and ventilation 
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distribution is the West zones of the lungs (8). This concept says that in a standing human, both 
ventilation and perfusion of the lungs increase from top to bottom due to gravity. The uneven 
distribution of blood flow can be explained by the hydrostatic pressure differences within the 
pulmonary blood vessels. The uneven distribution of ventilation can be attributed to the weight of 
the lungs, which makes the intrapleural pressure less negative at the bottom than at the apex of 
the lungs. As a consequence, the basal lung is relatively compressed but expands more on 
inspiration than the apex (8). However, when the human is in the supine position, these differences 
in ventilation and perfusion disappear with the result that basal and apical ventilation and perfusion 
become more uniform. This effect of gravity-driven ventilation/perfusion equalization is even 
pronounced in healthy human lungs in the prone position with respect to the supine position (9). 
This finding helps the anesthetist understand why patients with respiratory distress syndrome may 
benefit from being transferred to a prone position for ventilation. Similar changes appear in 
weightlessness. Ventilation and perfusion of the lungs become more uniform. Additionally and 
attributed to the cephalic blood volume shift in microgravity, the pulmonary blood volume 
increases, leading to a slightly improved diffusion capacity. Furthermore, the functional residual 
capacity (FRC) is reduced in weightlessness (10). Nevertheless, gas exchange in microgravity is 
seemingly no more efficient than that on Earth (11). Reciprocal changes are observed as gravity is 
increased to more than twofold of that on Earth (12). However, the classical concept of J. West 
became controversial at some point. Glenny et al. (13) showed that perfusion inequalities of the 
lungs depend mainly on the vascular tree and not only on gravity. This dependence was 
demonstrated in pigs in parabolic flights (13). Parabolic flights contributed therefore to a broader 
understanding of a central physiological matter. That these findings of gravitational physiology are 
of interest for anesthetists and are transferable to intensive care medicine, and anesthesia care is 
proven by several excellent reviews in the context of critical illness (14, 15).  
1.1.3 Human cardiovascular control in parabolic flight 
In addition to the vestibular system, the cardiopulmonary and vascular system has been 
investigated the most of all human macro-physiological systems in parabolic flight. How the 
cardiovascular system responds to the parabolic maneuver depends on the body position and on 
the fluid status of the subject. A standing or sitting body position is required to investigate the 
orthostatic system. Thus, in this section, the upright standing body position is referred to if not 
otherwise stated. The fluid status of subjects has not been controlled in any of the human 
cardiovascular parabolic flight studies but has been controlled for in one study of baboons (16). 
Parabolic flights generate rapid gravity transitions ranging from twofold of the gravity of the earth to 
near weightlessness. The two dominating effects on the human cardiovascular system are, first, a 
rapidly changing cardiac pre-load due to blood volume shift within the veins (fig. 1.2) and, second, 
rapid change of the hydrostatic pressure component of the arterial blood pressure with an impact 
on the baroreceptors in the carotid arteries (fig. 1.2). The arterial baroreceptor reflex, briefly 
baroreflex, and the Frank Starling mechanism are the two dominating mechanisms in controlling 
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the cardiovascular system in parabolic flight. To a lesser degree, the Bainbridge reflex is involved 
in cardiovascular regulation in parabolic flight as well (17). The baroreflex and the Bainbridge reflex 
are neural feedback loops that regulate cardiac function and vascular tone. These reflexes are 
composed of a sensory (afferent) arm, an integration center in the medulla oblongata in the central 
nervous system and an efferent motor arm. 
 
Figure 1.3: Simplified diagram of the reflex control of the human cardiovascular system in parabolic flight. 
The dashed gray boundaries of the venous part of the circulation represent potential blood pooling in the 
veins in an upright body position due to the huge compliance of the veins with respect to the arterial tree. 
The dashed gray contours of the heart represent the Frank Starling mechanism due to an increased 
ventricular filling in weightlessness. The two major cardiovascular reflexes, the high-pressure baroreflex on 
the arterial side and the low-pressure Bainbridge reflex on the venous side with its circuitries in the medulla 
oblongata and their efferent autonomic limbs are shown. The main effector organs of these reflexes are 
basically the heart and the resistance vessels. Modified from (18). 
The third of the major human cardiovascular reflexes, the Bezold-Jarisch reflex, plays no or only a 
marginal role in cardiovascular regulation in parabolic flights. The baroreceptors are high-pressure 
stretch receptors and are located in the vessel walls of the carotid sinus and the aortic arch. These 
receptors respond to changes in the dynamic and hydrostatic component of the arterial blood 
pressure. The information is transmitted via the vagus nerves to the medulla oblongata. After 
processing the information, the efferent signals control cardiac output and systemic vascular 
resistance via the autonomic nervous system (18). The Bainbridge reflex originates from low-
pressure stretch receptors at the vena cava, the right atrium and the pulmonary veins. This reflex 
responds to changes in the blood volume of the thoracic compartment and transmits its neural 
information via the vagus nerves. The vagal outflow to the heart is inhibited, and the sympathetic 
outflow is enhanced by increased pre-load leading to tachycardia (19). These reflexes taken 
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together lead to a classical response pattern of the autonomic nervous system in parabolic flight. 
The activity of the sympathetic nervous system is nearly doubled in the initial hypergravity phase, 
leading to tachycardia and a stable mean arterial pressure despite decreased cardiac pre-load due 
to further blood volume shift to the dependent parts of the body with respect to 1 Gz standing 
position. Then, after transition into weightlessness, the sympathetic nervous system activity 
decreases but is still 80% of its 1 Gz activity. The suppression of the sympathetic nerve lasts 
however only approximately 10 seconds, after which its activity becomes enhanced still in 
microgravity. During the second hypergravity phase, another strong sympathetic activation occurs 
(20). An initial baroreflex-mediated vagal heart rate response leads to a bradycardia immediately 
after transition into weightlessness. This bradycardia is followed by a gradual heart rate recovery 
during the remaining seconds of the microgravity phase due to parasympathetic withdrawal (21). 
 
Figure 1.4: The arterial pressure and heart rate dynamics in a representative subject in standing position 
during a parabola are shown. The graphs of the upper diagram represent the following: dotted line, heart 
rate; dashed line, mean arterial pressure at the heart level; and continuous black line, calculated mean 
arterial pressure at the level of the carotid baroreceptors. The lower diagram shows acceleration dynamics in 
the head-to-toe direction. Particular attention should be paid to the course of the mean arterial pressure at 
the level of the baroreceptors because this pressure is the central trigger for the responses of the autonomic 
nervous system. Furthermore, it must be emphasized that heart rate regulation based on an activation of the 
parasympathetic system occurs within one heartbeat. On the other hand, any regulations that are based on 
sympathetic nerve activation or parasympathetic withdrawal appear delayed. 
Both the baroreflex and the Bainbridge reflex are important for the anesthetist to know. Their 
interactions may explain a multitude of bradycardia episodes that are observed frequently after 
induction of spinal anesthesia especially in the parturient (22). The Frank Starling mechanism 
contributes additionally to the cardiac output increase in weightlessness. The cephalic blood 
volume shift leads to an increase in ventricular filling, which on the other hand promotes an 
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increase in the developed cardiac pressure (23, 24). This increase in inotropy cannot be explained 
by only changes in cardiac muscle filament overlap but must have molecular mechanisms as well 
(25). These mechanisms include an increase in the calcium release from the sarcoplasmic 
reticulum, an increased calcium sensitivity and the phosphorylation of contractile filaments (26). 
However, it is difficult to separate the regulation of cardiac function in intrinsic (Frank Starling 
mechanism) and extrinsic (autonomic nervous system) control mechanisms (25). As previously 
indicated, not only the veins of the legs but also the splanchnic circulation play a key role in gravity-
dependent volume shift. The importance of the splanchnic circulation for venous return was 
demonstrated by a parabolic flight experiment by measuring the cardiac output after transition to 
weightlessness in an upright body position once with and once without the venous tourniquet of the 
legs. The result of the experiment was that the cephalic volume shift originated one half each from 
the legs and from the splanchnic circulation (17). 
All of these complex control mechanisms of the cardiovascular system are in a fragile balance and 
can easily become disequilibrated, which has been demonstrated in previously orthostatic tolerant 
subjects after parabolic flights. Even the short periods of changing gravity of a parabolic flight 
increased orthostatic intolerance in half of the tested flight subjects (27). Interestingly, this was 
mainly the case in subjects who showed augmented hyperventilation, which led to hypocapnia and 
cerebral vasoconstriction (28). This important observation shows that the human brain is not an 
orthostatically passive organ that only receives its blood perfusion depending on the performance 
of the remaining cardiovascular system but has an active and regulating role in orthostasis in 
general (29). 
1.1.4 The heart in parabolic flight 
Cardiac output is regulated by the preload, contractility, heart rate and afterload (2). Cardiac output 
during rest in 1 Gz in the supine and standing positions is approximately 5-10 and 4-6 L*min-1, 
respectively, whereas that during exercise is approximately 15-21 L*min-1 in the supine and 16-18 
L*min-1 in the standing position, respectively (30). The cardiac output during rest in the supine 
position and during rest in weightlessness is comparable but it can increase after transition in a 
resting standing position into weightlessness to up to 16 L*min-1 without exercise stress (31). The 
blood volume shift that occurs in an upright stance in the parabolic maneuver allows the heart to 
first drain out blood, then receives a huge amount of blood and finally drains out blood again in just 
60 seconds. This drainage leads to the activation and deactivation of the sympathetic and vagal 
nervous system in rapid sequence. Furthermore, the chambers of the heart are dilated but only to 
shrink again a couple of seconds later (23). Thus it is not surprising that the human heart responds 
with arrhythmias to parabolic maneuvers in some cases. Supraventricular arrhythmias and 
premature ventricular contractions have been observed (32) (fig. 1.5). However, cardiac 
arrhythmias appear under hypergravity conditions as found in acrobatic flights and in centrifuges 
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as well (33). Furthermore, arrhythmic risk increases during long-duration weightlessness simulation 
by head-down tilt bed rest experiments (34). 
In actual weightlessness, premature ventricular contractions can appear in astronauts. One 
astronaut developed a short period of a ventricular tachycardia (35), and the Russian medical 
community reported more than 75 abnormal ECG recordings in flight in cosmonauts during the last 
10 years of the space station MIR (36). One cosmonaut had premature ventricular contractions 
before his first space flight. He finally flew without complications after the exclusion of 
morphological heart disease with beta blockers and calcium channel blocker medication (37). 
 
Figure 1.5: The upper graph shows a lead-II ECG tracing in a test subject who was exposed to a parabolic 
flight maneuver in the standing position. The lower graph shows acceleration in the head-to-toe direction. 
The subject received 175 µg of scopolamine before the flight. Premature monomorphic ventricular beats 
appeared repeatedly after transition to weightlessness and disappeared immediately after transition into the 
second hypergravity phase. Adapted from (32). 
1.1.5 The central venous blood pressure in parabolic flight and in space 
The intramural and transmural central venous pressure (CVP) plays a key role in the human 
circulatory regulation because it is one of the main determinants of ventricular filling, respectively 
pre-load, of the right and left heart. CVP depends on the relationship between cardiac output and 
venous return (38). The venous return, on the other hand, depends mainly on the mean systemic 
filling pressure, the stressed volume of the veins and the venous resistance (38). Before CVP had 
been measured in parabolic flight and in space for the first time, it was expected to increase in 
weightlessness above 1 Gz standing values because of the shift of 1-2 liters of blood from the 
dependent to the central compartments of the body. The first studies of CVP in baboons in 
parabolic flight showed a decrease in the CVP after transition to weightlessness if the baboon was 
volume depleted and an increased CVP if the baboon was volume replete (16). In humans in 
parabolic flight, the CVP was measured by Videbaek and Norsk, who showed a decreased CVP in 
weightlessness with respect to the 1 Gz supine position (39). In space, CVP was finally found to be 
lower than its value in the sitting position before launch (40, 41). These findings surprised the 
involved scientists, and a watertight explanation of these findings is still lacking. An increased 
cardiac output, an increased intrathoracic volume, a decreased intrapleural pressure and a 
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decreased weight of soft tissues are responsible for the CVP dynamics. These factors together 
lead to an increase in transmural pressure of the heart, which in turn increases cardiac output via 
the Frank-Starling mechanism (42, 43). However, the current knowledge on the CVP paradox in 
weightlessness makes clear that the CVP in space lacks a simple explanation, closing the circle to 
clinical medicine where CVP lost its significance for cardiovascular monitoring in critically ill 
patients and patients receiving anesthesia. This loss of significance occurred because CVP failed 
to demonstrate its validity in the determination of the fluid status of a patient and its ability to detect 
patients with fluid responsiveness (44, 45). However, the importance of an adequate CVP for 
cardiovascular function makes it not surprising that CVP remains unchanged despite very serious 
circulatory stress. 
The venous side of the circulation is difficult to access; therefore, parameters of this part of the 
vascular system are difficult to evaluate. Parameters, such as stressed and unstressed volume and 
mean systemic filling pressure, are crucial to understanding the venous and central venous system 
but are not part of the regularly measured parameters in patients receiving intensive care, although 
they could be of benefit for the treatment of the patient and for the understanding of hypovolemia 
(46, 47). Furthermore, these parameters have been measured in only patients receiving 
mechanical ventilation. To better understand the issue of the CVP in weightlessness and in critical 
care medicine, it must be emphasized that an increase in cardiac output leads to a decrease in the 
central venous pressure (1). Thus, cardiac output controls the central venous pressure when 
circulation is in the steady state and not vice versa. Cardiac output increases after transition into 
weightlessness (21, 48), and a decreased CVP therefore seems to be a logical physiological 
reaction. This response has led to much of confusion because right arterial pressure is often 
misinterpreted as the control variable of cardiac output (49, 50). However, there is a particular 
pathological type of circulation in which central venous pressure and systemic venous pressure 
together with pulmonary vascular resistance are the key determinants of cardiac output – the 
Fontane circulation (51, 52). In this single heart circulation control of central venous pressure is the 
monitoring method of choice for the anesthetist to avoid cardiac failure due to hypovolemia (53).  
1.1.6 Interactions of the cardiovascular, vestibular, visual and the postural systems 
The shift of blood in the vascular tree and the unloading of baroreceptors are not the only triggers 
of reflexes of the human body in parabolic flight. Further physiological systems that are highly 
challenged are the vestibular system, the visual system, the postural system and the viscera. The 
vestibular system is directly connected to the autonomic nervous system, which is called the 
vestibulosympathetic reflex (54). This reflex plays an important role in the control of blood pressure 
during gravitational stress (55, 56). The postural system, that guarantees the stance of the human 
body in three dimensions works therefore together with the cardiovascular system to maintain 
orthostasis under orthostatic challenge (57). The visual system (58), proprioceptors in axial and 
limb muscles and mechanoreceptors in the skin send further inputs to the vestibular nuclei in the 
central nervous system (59). These nuclei again send their afferents to regions of the brainstem 
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that regulate circulation and respiration. Furthermore, projections from visceral receptors modulate 
the circulatory and respiratory centers in the brainstem during gravitational stress (59).  
1.2 Methods 
1.2.1 The parabolic flight 
 
 
Figure 1.6: The Earth with its center of mass, X, and a theoretical orbit around this center is shown as 
dashed ellipse. A parabolic flight trajectory creates, from a physical point of view, the identical 
“weightlessness” that astronauts experience in space. At the peak segment of the parabola, the airplane 
follows the theoretical orbit around the center of mass of the Earth with an orbital period of approximately 30 
min. Adapted from (60).  
Parabolic flights using modified passenger airplanes have been performed for decades for 
scientific reasons and for astronaut training (60). Early reports of medical experiments performed 
during parabolic trajectories date back to the 1950s (61). The possibility of cheating gravity on 
earth by creating short phases of weightlessness by following a particular parabolic-shaped 
trajectory in an airplane was first systematically described by F. and H. Haber in 1950 (62). Based 
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on this concept, F. Haber later developed the roller-coaster flight pattern of the US parabolic flights 
for training the Apollo astronauts. In the same year, and before the first man entered space, the 
German physiologist Otto Gauer wrote a theoretical article on the potential effects of 
weightlessness on the human body (63), in which he correctly predicted some of the effects of 
weightlessness on the human inner ear. In addition to these scientific flights, touristic parabolic 
flights have become increasingly popular in recent years and will gain further importance as a 
training environment for costumers of the upcoming suborbital commercial space flights.  
 
Figure 1.7: Inertial force vectors acting on the body. Attention should be paid to the fact that accelerative 
force acts in an opposite direction to the inertial force. -Gz, footward acceleration; +Gz, headward 
acceleration; -Gy, left lateral acceleration; +Gy, right lateral acceleration; -Gx, backward acceleration; +Gx, 
forward acceleration. Adapted from (64). 
1.2.2 Design of a European parabolic flight campaign 
During a scientific European parabolic flight consisting of 31 parabolas, the participants experience 
approximately 11 minutes of weightlessness and approximately 21 minutes of hypergravity (1.8 
Gz). Two contiguous parabolas are separated by a phase of steady flight of one minute. Three 
flight days represent a scientific parabolic flight campaign, meaning that during a flight campaign, 
approximately 33 minutes of weightlessness and 63 minutes of hypergravity are produced.  
Since 2013, there have been touristic parabolic flight campaigns available in Europe. These 
campaigns contain a single flight day with 15 parabolas. These touristic flights will gain importance 
as training flights for the upcoming commercial suborbital space flights. Incidentally the suborbital 
flights follow a parabolic flight path and are therefore also parabolic flights, which, however, leave 
the atmosphere and enter space. 
Much of parabolic flight research is performed in the USA using different types of parabolic flight 
airplanes, e.g., a KC 135 and a Boeing 727. The US campaigns differ from the European 
campaigns by the flight profile and the number of parabolas that are flown per flight day. 
Additionally, the cabin atmosphere in the US parabolic airplanes is different from that of the 
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European Airbus A300 Zero-G. These differences are important to consider when the research 
results of US and European experiments are interpreted together. Parabolic flight research is also 
performed by the Japanese aerospace association using a Gulfstream II. 
1.2.3 The flight trajectory 
In aviation and gravitation medicine, inertial and accelerative forces are a pivotal concern. 
Newton’s third law of motion states that the inertial force of the body is equal to and opposite of the 
applied accelerative force. Thus, the headward acceleration of the parabolic airplane produces a 
footward inertial force, which becomes visible in the downward blood volume shift. The body axis in 
which the inertial force acts is referred to as either x, y, or z (fig. 1.7) (64). During a parabolic flight, 
accelerative forces in the x- and y-axes are negligible. The desired accelerative forces in the z-axis 
of 1.8 and 0 Gz are leveled by the pilots in the narrow range of ± 0.05 Gz. 
A single parabola consists of an initial hypergravity phase lasting approximately 20 seconds, 
followed by the actual microgravity phase of 22 seconds and completed by the second 
hypergravity phase of again 20 seconds (fig. 1.8).  
 
 
Figure 1.8: Parabolic flight profile with a hypergravity phase at the beginning and at the end of the parabola 
and the microgravity phase in the middle. The microgravity phase already starts when the airplane is 
climbing. Adapted from (32). 
1.2.4 The airplane 
The airplane that is used for the European parabolic flights is one of the first ever built Airbus 
aircrafts. This aircraft is an A300 B2-C1 with the serial number 003 and was built in 1973. Between 
1973 and 1996, this aircraft was used by the Airbus Company for flight testing. In 1996, it was then 
modified to serve as a parabolic flight test airplane, and the first European parabolic flight 
campaign with this aircraft was flown in 1997. This airplane is owned by the French Novespace 
company and is located at the Bordeaux Merignac airport in France. The parabolic flight 
campaigns are performed by test pilots and test flight engineers of the French test flight center 
Centre d’Essais en Vol (CEV). The parabolic flights are usually flown in a protected airspace over 
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Brittany or the Mediterranean Sea close to Corsica. In the middle sector of the airplane, there is a 
100-m2 experimentation zone without seats that offers space for 12-15 experiments per flight (60). 
1.2.5 The cabin atmosphere 
The European A300 Zero-G performs its flights at an altitude of 6.000 – 9.000 a. m. s. l. The cabin 
atmosphere during the flight is very dry, the humidity is approximately 15%, and the environment is 
slightly hypobaric and hypoxic. The ambient pressure of the cabin in flight is 825-830 mbar, which 
is equivalent to an altitude of approximately 1650 a. m. s. l. This hypobaric hypoxia makes the 
A300 an excellent simulation facility for space flight (tab. 1.1).  
Location or facility 
Altitude  
(m.a.s.l.)  Ambient pressure (hPa) FiO2 
pO2 
(ATP) 
pO2  
(BTPS) pH2O (hPa) RQ 
pACO2 
(hPa) 
pAO2 
(hPa) 
Sea level 0 1013 0.21 213 200 62.5 0.8 47.9 142 
Cabin Space Shuttle (65) 0 703 0.26 183 167 62.5 0.8 47.9 109 
Int. Space Station (66) 0 1013 0.21 213 200 62.5 0.8 47.9 142 
Cabin A300 Zero-G# 1650 830 0.21 173 160 62.5 0.8 47.9 102 
Zugspitze  
Schneeferner Haus 2650 714 0.21 150 137 62.5 0.8 40 89 
Summit of Mt. Everest (67) 8848 253 0.21 53 40 62.5 0.8 17 21 
Capanna Margherita (68) 4554 592 0.21 124 111 62.5 0.8 30 76 
Concordia Antarctic Station (69) 3233 645 0.21 135 122 62.5 0.8 35 81 
Mars/Lunar habitat (65) 4877 552 0.32 177 157 62.5 0.8 47.9 99 
Space suit (65) 4877 552 1.0 552 490 62.5 0.8 47.9 432 
Scuba diving (20 m) -20 3039 0.21 638 625 62.5 0.8 47.9 567 
PlanHab (70) 900 951 0.15 143 133 62.5 0.8 47.9 75 
Hyperbaric oxygen therapy (71) 0 2026 1.0 2026 1964 62.5 0.8 47.9 1906 
Table 1.1: The ambient pressure, oxygen fraction and oxygen partial pressures of relevant research facilities 
are given. Hypoxia in the A300 cabin is similar to theoretical hypoxia in Martian habitats. #, own 
measurements.  
Special consideration should be given to the atmosphere of the A300 with respect to the 
atmosphere of planned future lunar and Martian habitats. The habitats on the moon and Mars will 
most likely have an atmospheric pressure that is equivalent to an altitude of approximately 5000 a. 
m. s. l. and an oxygen fraction of 32% (65). The result of this particular atmosphere would be an 
only slightly lower partial oxygen pressure than that in the cabin of the A300. However, considering 
that the partial pressure of water vapor does not depend on the ambient pressure but on the 
ambient temperature, it becomes clear that this pressure is always 62.5 hPa at 37°C in the lungs. 
The consequence is that the water vapor pressure would decrease the alveolar oxygen partial 
pressure more under the conditions of a future lunar and Martian habitat than it does under the 
conditions of the A300 cabin atmosphere. The result of these considerations is that the level of 
hypoxia of the A300 cabin and future habitats is comparable, making the A300 an effective 
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approach to investigate human physiology not only under the gravity conditions of a space flight 
but also under atmospheric conditions. 
1.2.6 Flight medication 
The participants of the European parabolic flights aboard the A300 Zero-G receive scopolamine 
hydrobromide injected subcutaneously before their flight as anti-motion sickness prophylaxis 
(women: 125 µg; men: 175 µg). Scopolamine has extensively demonstrated its capability in 
avoiding motion sickness (72). In case of severe in flight motion sickness, certain flight participants 
receive a second shot during the flight by the flight surgeon. Scopolamine or Hyoscine is an 
anticholinergic alkaloid drug with muscarinergic antagonistic effects. Except for dry mouth and 
eyes and slight dizziness, no serious side effects of the drug on the test subjects were observed in 
the context of this thesis. In particular, there was no distinct tachycardia, and all of the subjects 
showed a competent orthostatic regulation during their flight. 
 
Figure 1.9: The in-flight experiment setup of the parabolic flight experiment that led to the results of chapters 
three and four is shown. The experiment team consists of five individuals. The experiment leader is sitting in 
front of the experiment rack strapped to the ground and triggers the rebreathing maneuvers of the two 
subjects in weightlessness. The two subjects are free-floating and performing rebreathing maneuvers via a 
face mask and are only slightly assisted by the two operators behind them. The experiment rack includes two 
rebreathing devices, two laptops for data storage, two finger blood pressure devices and two ECG and ICG 
BIOPAC devices. The test tubes for blood sampling are fixed at the front sides of the rack. In the left lower 
corner, the cooler for blood sampling storage is visible.  
Chapter 1 
25 
1.2.7 Medical considerations of parabolic flights 
Participating in a parabolic flight requires a medical checkup before the flights. This checkup can 
be performed by a specialized flight surgeon or by the family doctor of the participant with the 
support of the parabolic flight authorities. The checkup is equivalent to a JAR III medical license, 
which is mandatory for private pilots. Several diseases prevent parabolic flight candidates from 
participating. Table 1.2 presents an overview about the absolute and relative disease states that 
complicate or prevent participation. 
Exclusion criteria Expertise of a cardiologist is required Re-evaluation at a later date 
Heart failure Coronary artery disease Recently started or changed therapy of arterial hypertension 
Myocardial infarction or coronary bypass 
surgery < 6 months ago 
Any type of cardiac arrhythmia and 
conduction disorder  
Major heart valve anomaly Any „abnormal“ ECG  
Poorly controlled arterial hypertension Myocardial infarction or coronary bypass surgery > 6 months ago  
Non-cardioselective β-blockers Minor heart valve anomaly  
Insulin-dependent diabetes mellitus I° or II° Accumulation of cardiac risk factors  
Table 1.2: Summary of the medical regulations of the Novespace company (73). 
1.3 Ground-based facilities and measurement techniques 
Each method that was applied for this thesis is described in detail in later chapters. However, this 
section aims to bring the methods in line with the medical and clinical context and the medical 
literature. 
1.3.1 The hypobaric chamber at the DLR 
The hypobaric chamber (fig. 1.10) at the DLR Institute of Aerospace Medicine in Cologne is a 
cylindrical tube that is 2.8 meters long and 2 meters high.  
 
Figure 1.10: The hypobaric chamber at the Institute of Aerospace Medicine of the German Aerospace 
Center in Cologne. 
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Suction pumps decompress the chamber to create an ambient pressure that is equivalent to any 
desired altitude. Thus, the chamber is adequate for investigating the effects of short de- and re-
compression on the human body, making the chamber essential for medical research in 
aeronautics and mountaineering. The chamber provides seats for up to 6 people, and experiments 
can be performed in the sitting and standing positions. Equipment can still be transferred into and 
out of the chamber during the decompression phase via an air lock. For the experiments of this 
thesis, the subjects stayed in the chamber for four hours, with three hours of air pressure reduced 
to 830 mbar. 
1.3.2 Blood volume determination by carbon monoxide rebreathing (CORB) 
Traditional blood volume determination, based only on hematocrit and hemoglobin values, could 
not demonstrate its equality in terms of reliability with respect to dye dilution techniques. In 
particular, the widely used method of Dill and Costill (74) showed an underestimation of blood 
volume changes of up to 50% during antiorthostatic maneuvers (75). Therefore, the optimized 
carbon monoxide rebreathing method (CORB) (76) was used for plasma and blood volume 
determination within the framework of this thesis. This method uses small amounts of carboxy-
hemoglobin (COHb) as its dye to determine the total hemoglobin mass (tHb). Carbon monoxide is 
taken up by the subjects via the lungs by carbon monoxide rebreathing. Measurements of the 
COHb fraction are performed before and after the carbon monoxide rebreathings via the 
Radiometer ABL 725 blood gas analyzer (Diamond Diagnostics, MA, USA), which has 
demonstrated its feasibility for COHb determination (77). For this thesis, a maximal 2-month 
interval between the CORB procedure and the actual experiments in parabolic flight and hypobaric 
chamber was met and seemed adequate because the individual total Hb mass is very stable over 
time. Eastwood and colleagues found a variation in the total Hb mass of only less than 2% over 
100 days (78). By assuming the same total hemoglobin mass during the flights and hypobaric 
chamber runs as that during the actual rebreathing procedure, the intravascular volumes could be 
calculated from venous blood counts, which were drawn during the flights and the chamber runs. 
The actual total hemoglobin mass was corrected considering Hb mass loss due to the 16 ml of 
blood that was drawn at each sampling using the following equation: 
ቈtHbሺgሻ െ ቆ16ሺmlሻ ∗ Hb ቀ gdlቁቇ቉ 
The CORB method has demonstrated its feasibility in sports medicine and altitude training 
physiology predominantly (79, 80). CORB is safe, and carbon monoxide rebreathing has been 
successfully applied to animals (81) and critical ill patients receiving mechanical ventilation therapy 
(82, 83). Patients with critical illness in particular suffer from anemia regularly, but an actual 
threshold below which these patients would benefit from blood transfusion is still lacking. However, 
in their recent review on anemia in the critically ill, Astin and Puthucheary reported that measuring 
the total hemoglobin mass (tHb) could be useful for assessing more accurately the transfusion 
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needs of patients receiving intensive care (84). These authors hypothesized a so-called 
neocytolysis, a programmed destruction of new red cells, in critically ill patients. Neocytolysis has 
been demonstrated in astronauts returning to earth and in high-altitude climbers returning to the 
plain, leading to a reduction in red cell mass in these individuals (85, 86).  
1.3.3 Biochemical analyses of parabolic flight and hypobaric chamber blood samples 
The blood osmolality was determined in serum by the freezing point depression method (OM 801, 
Vogel GmbH, Giessen, Germany). In this method, 280–300 mosmol/kg was given by the executing 
laboratory as a normal range. Albumin was determined in the blood serum by a BCG dye-binding 
assay (ADVIA 1800, ADVIA Chemistry Systems, Siemens Health Care Diagnostics GmbH, 
Eschborn, Germany). The albumin normal range was stated as 35.0 – 52.0 g/L. The blood cortisol 
concentration was determined from the serum by an ELISA assay, with 4.3 – 22.4 µg/dl as the 
normal range (Siemens ADVIA Centaur Cortisol, Siemens AG, Munich, Germany). The direct renin 
activity (DRA) measurement was performed in EDTA plasma by a chemiluminescence immuno 
assay (LIAISON Direct Renin, DiaSorin S.p.A., Saluggia, Italy) (87). The normal range for DRA 
was set for the upright body position at 2.46 – 25.8 pg/ml. The blood aldosterone concentrations 
were measured in serum by an ELISA assay (DB 52001, IBL International GmbH, Hamburg, 
Germany). The aldosterone normal range in the upright body position was given as 40.0 – 310.0 
pg/ml. To measure the behavior of arginine vasopressin (AVP) during the parabolic flight and 
hypobaric chamber tests, we determined the concentration of the C-terminal part of the AVP 
precursor (copeptin) in the blood serum via an immunofluorescent assay (B·R·A·H·M·S Copeptin 
us KRYPTOR, B·R·A·H·M·S GmbH, Hennigsdorf, Germany). The normal range of copeptin 
depends on the blood osmolality. For a blood osmolality between 291 and 300 mosmol/kg, the 
normal range of copeptin is 2.3 – 28.2 pmol/L. Morgenthaler et al. reported the high stability of 
copeptin in serum, unlike mature AVP, which can be considered the most relevant advantage of 
the copeptin assay (88). NT-proBNP, as a stable surrogate of BNP, was determined by a 
chemiluminescent immunometric assay in the EDTA blood plasma (IMMULITE 2000 systems, 
Siemens AG, Munich, Germany). The cut-off value for heart failure was set by the laboratory at 
125 pg/ml. 
1.3.4 Cardiac output determination via inert gas rebreathing 
The method of cardiac output determination by inert gas rebreathing was applied in flight and in the 
hypobaric chamber. For this thesis, the Innocor® device from Innovision® was used, which is a 
spin-off of the pulmonary function system that is used aboard of the International Space Station. 
This device is a closed breathing system that uses nitrous oxide (N2O) as a test gas. The subject 
inhales and exhales a particular gas mixture from and to a rubber bag. N2O is taken up by the 
pulmonary blood flow, the blood flowing through the lungs (fig. 1.9). The amount of N2O remaining 
in the exhaled air is measured by a photoacoustic sensor. The amount of N2O uptake is 
proportional to the pulmonary blood flow, which is, in turn and in the absence of any significant 
pulmonary shunt, equivalent to the cardiac output. The bag volume and breathing frequency do not 
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influence the reliability of the method in a wide range (89, 90). The test subjects performed the 
rebreathing procedure with a respiratory rate of 20 breaths per minute in approximately 15 
seconds. Thus, rebreathing maneuvers form in the limits with least effects on CO, as postulated by 
Damgaard and Norsk (90). The stroke volume (SVrb) was calculated afterward by dividing the 
pulmonary blood flow (PBF) by the heart rate (HR) from ECG. The HR determined by Innocor from 
a finger pulse oxymeter plethysmogram could not be used because Innocor uses the average HR 
value from a 30-second interval just before the actual rebreathing (personal communication of 
Innovision). The cardiac index (CIrb) and stroke index (SIrb) were then obtained by dividing the COrb 
and SVrb by the body surface area, which was calculated automatically by Innocor using the 
formula of Du Bois and Du Bois (91).  
The very first uptake of N2O during the first inhalation of a rebreathing is not driven by the 
pulmonary blood flow but by its rapid uptake into the pulmonary tissues. A similar effect is known in 
anesthesiology as the concentration effect (92). This effect can therefore be used to quantify the 
volume of the pulmonary tissues. The combined lung tissue volume and capillary blood volume 
(Vti,c), hence the volume of solvent, are calculated by the Innocor device based on the initial 
decrease in N2O concentration (93). Again, it is assumed that the volume of N2O that is absorbed 
by the lung is measured during the midinspiratory time of the first inhalation from the bag before 
the gas is taken up in significant amounts by the capillary blood flow (93-95). Furthermore, the 
alveolar oxygen consumption (VO2) is determined by Innocor during rebreathings assuming that 
the slope of the disappearance curve for O2 is proportional to the oxygen uptake (93, 96). 
In clinical medicine, the method of cardiac output determination by nitrous oxide rebreathing is 
established in exercise function testing in patients suffering from heart failure or severe lung 
disease (97, 98). Furthermore, the first attempts have been performed to use the nitrous oxide 
rebreathing technique for cardiac output determination in critically ill patients receiving mechanical 
ventilation (99-101). In these cases, a mass spectrometer has been used. In patients with severe 
lung failure who were treated with artificial ventilation in the prone position, this method was able to 
identify responders to the prone position by measuring the pulmonary blood flow (102). The 
Innocor device, as a bedside device, has not yet been adapted for measurements in ventilated 
patients but has successfully been tested in ventilated dogs (103).  
1.3.5 Cardiac output determination via impedance cardiography 
Impedance cardiography, a non-invasive and continuous approach, measures the flow changes in 
the aorta and was developed nearly 50 years ago by WG Kubicek (104, 105). This technique is 
based on the application of a small alternating current of, for example, 1 mA and 100 kHz via 
electrodes to the chest. Via further electrodes, the electrical resistance of the thorax is measured. 
Usually, the electrical current flows along the path of the smallest electrical resistance. Within the 
chest, the heart and the aorta have the smallest electrical resistance of all of the structures 
because they contain blood with a very low specific electrical resistance. Therefore, changes in the 
stroke volume and flow in the aortic arch are related to changes in the thoracic impedance. Based 
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on the law of Ohm, which states that ܷ ൌ ܴ ൈ ܫ, where U, R and I stand for voltage, resistance and 
current, respectively, thoracic impedance can be calculated by ܴ ൌ ௎ூ . Unfortunately, R is named Z 
in the context of bioimpedance. As a first basic measure, the first derivate of Z is calculated (dZ/dt). 
The area under the dZ/dt curve correlates with the cardiac stroke volume (106). Different 
algorithms exist to determine the actual stroke volume from the bioimpedance signal. For this 
thesis, the formula of Kubicek was used, which is based on a simplified single cylinder model of the 
human thorax (105). Kubicek’s formula states (107) the following: 
where SV is stroke volume (ml), ρ the resistivity of blood (Ω • cm), L the distance between the 
voltage measuring electrodes (cm), Z0 the basic thoracic impedance (Ω), dZ/dtmax the maximal 
impedance change (Ω/s) and LVET the left ventricular ejection time (s). The main determinants of 
SV are the left ventricular ejection time (LVET) and dZ/dt (108), which lead to a major problem of 
impedance cardiography, namely the unreliability of the LVET determination. This is shown in 
figure 1.11.  
  
Figure 1.11: The left graph shows the first derivate of the thoracic impedance and a simultaneous ECG 
recording during a single heartbeat. The B and X points taken as LVET identifier are shown among others. 
Adapted from (107). The right graph provides a representative recording of the first derivate of the thoracic 
impedance during a single heart beat in one of the parabolic flight subjects in the standing position in 1.8 Gz 
(ICG 1.8), 1.0 Gz (ICG 1.0) and microgravity (ICG 0). The change in shape of the curves is clearly visible. 
The shape of the first derivate of the thoracic impedance has a certain analogy with the arterial 
pulse curve. The B and X points determine the ejection period of the left heart chamber. However, 
the exact location of the X point in particular is usually difficult to detect, and uncertainty in locating 
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the X point leads to an incorrect ejection period and thus to an incorrect stroke volume. Therefore, 
bioimpedance has failed to demonstrate its accuracy in cardiac output determination in intensive 
care patients (109), although its advantages are obvious. In addition to cardiac output, 
bioimpedance provides information on the heart on a beat-to-beat basis, including systolic time 
intervals, which are not assessable by other non- or minimally invasive cardiac output monitoring 
systems (110). 
1.3.6 Cardiac output determination via pulse contour analysis 
 
Figure 1.12: Changes in the shape of the non-invasive arterial finger pressure curve during a parabola in a 
representative upright subject. The green graph was taken in 1.8 Gz, the red graph was taken in 1.0 Gz, and 
the blue graph was taken in weightlessness. It is clearly visible that the pulse curve at 0 Gz gained a second 
and a third systolic maximum with respect to 1.0 and hypergravity. Thus, the determination of the systolic 
time interval (LVET) becomes more difficult. 
The famous physiologist Otto Frank thought in 1930 about how to estimate cardiac stroke volume 
by analyzing of the aortic pressure curve (111). His intention was to obtain a technically simple and 
cheap method for cardiovascular research (112). The basic idea of stroke volume estimation 
through pulse curve analysis is that blood pressure and blood flow are correlated. The advantage 
of stroke volume determination via pulse contour analysis is that the stroke volume can be 
estimated online on a beat-to-beat basis. Therefore, for this thesis, the pulse curve of the arterial 
pressure of a finger was measured noninvasively by the volume clamp method of the Czech 
physiologist J Penáz (113). The Finometer MIDI® device from FMS® system was used for this 
purpose. However, the sticking point is that based on the pressure, information of the peripheral 
circulation flow of the central circulation must be back calculated. Wesseling and coworkers 
developed a generally accepted and widely used non-linear three-element model of the aortic input 
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impedance. This model calculates an aortic flow waveform from peripheral arterial pressure (114). 
Their method is based on the area under the systolic pressure curve and on the aortic impedance 
(115). For this thesis, we used the Modelflow method, which is based on the original Wesseling 
formula but was developed further and considers more parameters (116). However, in patients 
receiving cardiac surgery, the method demonstrated its reliability when the radial arterial pressure 
was measured invasively (117). The measurements of this thesis used non-invasive finger blood 
pressure measurements; thus, it is important to note that non-invasive and invasive arterial blood 
pressure measurements agree in healthy subjects under gravitational stress (118). In healthy 
subjects undergoing a bleeding simulation via a lower body negative pressure test (LBNP), the 
Modelflow method was therefore able to track progressive hypovolemia (119). On the other hand, 
a good agreement between invasive and non-invasive beat-to-beat blood pressure measurements 
is not the case in intensive care patients with peripheral edema or with the need for catecholamine 
therapy (120). Reflections of the arterial pulse wave lead to the propagation of the peripheral pulse 
curve and complicate deducing the central circulation. In general, pulse wave reflections increase 
when the total peripheral resistance decreases (121).  
 
Figure 1.13: The pulse pressure curve of the radial artery includes not only the forward pulse wave of the 
ejection of the heart but also the backward pulse waves as reflected from the renal arterial branch and the 
iliac arterial bifurcation. Adapted from (122). 
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Appendix 
The original publication presented in this chapter contains supplementary material in the form of 
online references that can be found on the homepage of the European Journal of Applied 
Physiology: http://link.springer.com/article/10.1007%2Fs00421-014-2856-3. 
Online reference 1 contains a video showing an inflight measurement sequence. The 
supplementary texts of online reference 2 regarding the CORB and the inert gas rebreathing 
method as well as the biochemical blood analyses have been included in the methods section of 
chapter one of this thesis. The supplementary numerical results of online references 3 to 6 are 
shown below. 
Parameter GroundPre Outbound Gz Block I  Block II  Block III  Block IV  Return GroundPost 
HR 100 ± 15 93 ± 18 0 92 ±15  81 ± 14 81 ± 15 78 ± 12 95 ± 11 91 ± 12 
(bpm)   1.8 123 ± 21 113 ± 19 111 ± 17 110 ± 15   
FBPsyst  127 ± 22 136 ± 21 0 144 ± 26 120 ± 30 121 ± 26 123 ± 22 124 ± 23 126 ± 14 
(mmHg)   1.8 148 ± 21 132 ± 27 127 ± 24 131 ± 20   
FBPdiast 72 ± 14 74 ± 14 0 70 ± 14 61 ± 17 60 ± 12 62 ± 12 76 ± 15 78 ± 10 
(mmHg)   1.8 86 ± 14 85 ± 16 80 ± 14 83 ± 15   
FBPmean 90 ± 15 93 ± 15 0 94 ± 16 81 ± 17 80 ± 15 81 ± 14 91 ± 18 92 ± 10 
(mmHg)   1.8 105 ± 14 101 ± 17 96 ± 15 96 ± 19   
SIrb 29 ± 8 33 ± 7 0 55 ± 11 58 ± 13 55 ± 8 53 ± 12 28 ± 6 26 ± 5 
ቀ࢓࢒࢓૛ቁ  
  1.8 28 ± 8 24 ± 4 ± 23 ± 4 24 ± 4   
CIrb  2.905 ± 0.678 3.052 ± 0.746 0 5.139 ± 1.326 4.742 ± 1.260 4.364 ± 1.038 4.150 ± 1.082 2.622 ± 0.542 2.564 ± 0.757 
ቀ ࡸ࢓࢏࢔ൈ࢓૛ቁ  
  1.8 2.986 ± 0.743 2.653 ± 0.418 2.486 ± 0.411 2.677 ± 0.446   
SVR  19 ± 5 18 ± 5 0 11 ± 3 11 ± 4 11 ± 3 12 ± 6 20 ± 6 23 ± 6 
ቀ ࢓࢓ࡴࢍࡸൈ࢓࢏࢔ ቁ   
  1.8 19 ± 5 23 ± 5 23 ± 5 21 ± 5   
 
Online reference #3 
 
 
Parameter GroundPre Outbound Gz Block I Block II Block III Block IV Return GroundPost 
SpO2  98 ± 0.6 95 ± 2 0 96 ± 2 95 ± 2 95 ± 2 95 ± 2 97 ± 2 97 ± 4 
(%)   1.8 96 ± 1 95 ± 2 95 ± 2 95 ± 2   
Vt  0.593 ± 0.181 0.688 ± 0.230 0 0.885 ± 0.458 0.737 ± 0.384 0.797 ± 0.642 0.729 ± 0.391 0.627 ± 0.230 0.542 ± 0.177 
(L)   1.8 0.858 ± 0.357 0.870 ± 0.417 0.938 ± 0.562 0.783 ± 0.445   
VO2 3.9 ± 1.1 4.0 ± 1.2 0 9.6 ± 2.4 9.4 ± 2.8 8.8 ± 2.4 8.1 ± 2.6 3.2 ± 0.8 3.1 ± 1.0 
(ml/kg*min)   1.8 4.0 ± 1.2 3.3 ± 0.9 3.2 ± 1.0 3.3 ± 1.2   
 
Online reference #4 
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Parameter GroundPre Outbound Block I 1G Block II 1G Block III 1G Block IV 1G Return GroundPost 
Cardiovascular         
HR (bpm) 
 
81 ± 11 76 ± 9 76 ± 10 74 ± 9 76 ± 10 77 ± 8 79 ± 10 79 ± 10 
FBPsyst (mmHg) 117 ± 16 123 ± 12 122 ± 14 124 ± 18 117 ± 14 118 ± 20 116 ± 18 124 ± 20 
FBPdiast (mmHg) 68 ± 12 68 ± 10 71 ± 14 73 ± 18 70 ± 15 70 ± 19 68 ± 18 75 ± 18 
FBPmean (mmHg) 85 ± 12 86 ± 10 87 ± 14 89 ± 18 85 ± 15 85 ± 20 84 ± 18 90 ± 18 
SIrb ቀ࢓࢒࢓૛ቁ 
31 ± 7 36 ± 10 32 ± 8 35 ± 8 34 ± 8 34± 9 33± 8 30± 8 
CIrb ቀ ࡸ࢓࢏࢔ൈ࢓૛ቁ 
2.509 ± 0.618 2.673 ± 0.714 2.423 ± 0.632 2.600 ± 0.679 2.561 ± 0.568 2.591 ± 0.695 2.538 ± 0.592 2.345 ± 0.561 
SVR ቀ ࢓࢓ࡴࢍࡸൈ࢓࢏࢔ ቁ 
84.5 ± 12.2 86.0 ± 9.9 87.2 ± 14.2 89.4 ± 18.3 84.8 ± 14.7 84.7 ± 19.6 83.7 ± 18.0 90.3 ± 18.0 
Respiratory         
SpO2 (%) 98 ± 0.6 96 ± 2 96 ± 2 96 ± 2 96 ± 3 96 ± 2 96 ± 2 98 ± 1 
Vt (L) 0.694 ± 0.185 0.600 ± 0.243 0.560 ± 0.207 0.598 ± 0.226 0.562 ± 0.209 0.584 ± 0.214 0.535 ± 0.151 0.636 ± 0.171 
VO2/kg (ml) 3.0± 0.9 3.2 ± 0.9 3.0 ± 1.0 3.1 ± 1.1 3.1 ± 0.8 2.9 ± 1.0 3.1 ± 1.0 2.7 ± 0.9 
 
Online reference #5 
 
 
Parameter Facility GroundPre Outbound Post 16th Post 31st GroundPost 
Plasma Volume (ml) Airplane 3375 ± 602 3414 ±592 3299 ±527 3330 ±571 3352 ±659 
 Chamber 3126 ±732 3241 ±726 3067 ±662 3074 ±692 3206 ±704 
Albumin ቀࢍࡸቁ 
Airplane 46.3 ±2.9 46.0 ±3.1 47.3 ±2.7 46.9 ±4.2 47.9 ±2.8 
 Chamber 45.7 ±3.0 44.4 ±2.2 47.0 ±9.4 46.5 ±2.4 45.1 ±2.5 
#Cortisol ቀஜࢍࢊ࢒ቁ 
Airplane 17.4 ±3.7 12.9 ±4.0 13.2 ±4.5 12.3 ±6.2 11.0 ±4.8 
 Chamber 14.0 ±6.7 11.9 ±4.1 10.6 ±3.1 10.4 ±4.0 10.2 ±3.3 
Aldosterone ቀ࢖ࢍ࢓࢒ቁ 
Airplane 126.5 ±51.7 146.2 ±58.0 160.2 ±74.1 157.9 ±70.5 165.5 ±64.9 
 Chamber 157.0 ±78.9 154.0 ±78.9 168.5 ±80.8 155.2 ±78.0 137.1 ±77.9 
‡Reninactive ቀ࢖ࢍ࢓࢒ቁ 
Airplane 10.8 ±4.8 12.5 ±8.0 13.2 ±9.0 13.6 ±8.6 13.5 ±7.3 
 Chamber 10.9 ±9.5 11.0 ±9.8 16.3 ±16.6 14.8 ±13.8 13.9 ±12.7 
Osmolality ቀ࢓࢕࢙࢓࢕࢒࢑ࢍ ቁ 
Airplane 312.1 ±15.1 310.8 ±10.8 310.7 ±14.0 312.1 ±16.2 308.8 ±13.3 
 Chamber 300.5 ±4.9 301.2 ±5.3 300.5 ±4.0 299.8 ±4.2 298.7 ±4.4 
#CT-proVasopressin ቀ࢖࢓࢕࢒ࡸ ቁ 
Airplane 9.4 ±11.7 6.3 ±7.2 5.3 ±5.1 8.5 ±10.0 4.9 ±3.8 
 Chamber 4.2 ±3.4 3.4 ±1.6 3.2 ±1.9 4.1 ±2.8 3.7 ±2.2 
NT-proBNP ቀ࢖ࢍ࢓࢒ቁ 
Airplane 65.9 ±52.5 66.9 ±50.5 72.9 ±57.1 73.6 ±51.6 66.8 ±45.9 
 Chamber 60.6 ±43.9 58.7 ±39.3 57.5 ± 36.2 57.2 ±35.3 59.3 ±33.6 
 
Online reference #6 
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Chapter Five 
5 Final considerations and clinical implications 
What can we learn from this work for clinical physiology and medicine? This thesis addresses 
many aspects; however, the four main points of its content are as follows: first, how do non-
invasive methods of cardiac output determination perform in non-steady state cardiovascular 
conditions; second, how does cardiac output, as the key variable of the circulation, behave during 
intense orthostatic and anti-orthostatic stress; third, how does pulmonary circulation react to 
orthostatic and anti-orthostatic stress in a hypoxic environment; and fourth, how do the human 
endocrine system and plasma volume respond to a combination of hypobaric hypoxia and gravity 
changes. 
5.1 Cardiac output determination in non-steady state cardiovascular conditions 
In general, methods of cardiac output determination can be categorized into ‘invasive’ and ‘non-
invasive’, ‘calibrated’ and ‘uncalibrated’, ‘absolute’ and ‘relative’, ‘continuous’ and ‘intermittent’ and 
into the categories of the principles of how they work. The four main function principles are the 
Doppler method, the applied Fick’s principle, bioimpedance and pulse wave analysis (1). Each of 
these methods has particular advantages and disadvantages. Usually, the more invasive the 
method is, the more exactly it works. However, the more invasive a method is, the more 
complications its application generates. Calibrated and absolute methods provide true 
cardiovascular indices, and continuous methods provide trends. Only non-invasive methods of 
cardiac index estimation are applied in space flight-related research due to the already complex 
and hostile environmental conditions. The procedural risks of cardiac output determination as 
related to space flight must not increase the overall risk of the mission. The results of these 
measurements may be therefore only relative or intermittent. However, the approach of non-
invasive cardiovascular index estimation is also gaining importance in clinical and intensive care 
medicine. This trend began with the abandoning of cardiovascular monitoring based on the highly 
invasive pulmonary artery Swan-Ganz catheter after less-invasive methods were developed (2), 
and it continues in the effort of establishing uncalibrated or non-invasive cardiovascular monitoring 
methods in intensive care medicine (3, 4). Two still promising methods of minimal or non-invasive 
cardiovascular monitoring in intensive care medicine are the bioimpedance method and the pulse 
curve analysis (5-8). Although these methods have so far shown a lack of precision in cardiac 
output determination in critically ill patients compared to thermodilution techniques, they still have 
the ability to become an established part of clinical cardiovascular monitoring. This ability is 
especially the case under the perspective of an integrative approach of cardiac output monitoring 
(9). Both of these methods are also well established in space flight-related research and in 
operational space medicine because of the need of this field for riskless monitoring methods. The 
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question is therefore ‘can we learn something new about these methods by testing them in space 
flight-related environments’? The answer is ‘yes’ because test environments, similar to parabolic 
flights, create a unique cardiovascular stress with great bidirectional volume shift. By undergoing 
the parabolic flight maneuver in a standing body position, the thorax of the test subjects gets 
volume depleted and volume re-substituted within seconds, leading to significant changes in the 
cardiac output and systemic vascular resistance. Testing bioimpedance and non-invasive pulse 
curve analysis in this setting are therefore very different from the tests of these methods in an 
intensive care setting where the cardiovascular system of the patient is carefully maintained in a 
steady state. This interesting point can be illustrated by comparing the results of this thesis with the 
results of the work of Sun et al. (10). Sun and colleagues compared different methods of cardiac 
output estimation based on arterial pressure measurement to thermodilution in intensive care 
patients. These authors found that the old method of Liljestrand and Zander from 1928 performed 
very well in this population, which was surprising because the algorithm is based on only pulse 
pressure divided by the sum of systolic and diastolic pressure multiplied by a calibration factor 
൬ܥܱ ൌ ௉ೞ೤ೞ೟ି௉೏೔ೌೞ೟௉ೞ೤ೞ೟ା௉೏೔ೌೞ೟ ൈ ݇൰ (11). Compared to the patients in an intensive care unit (as reported by Sun 
et al.), who had a mean cardiac output of 5 L/min and a mean range of 2 L/min per patient, the 
subjects of this thesis were measured during cardiovascular transitions that were induced by rapid 
gravity changes. This difference resulted in great changes in the cardiac output between 3 and 16 
L/min and in the total systemic resistance. The consequence was that none of the arterial pulse 
methods performed best under all gravity conditions. Although Wesseling’s corrected aortic 
impedance method (12) showed the lowest error in 1 and 1.8 Gz, the mean arterial pressure (MAP) 
and the Liljestrand and Zander method had the lowest errors in 0 Gz (13). In 0 Gz, a decreased 
total peripheral resistance can be observed with a great impact on the performance of the arterial 
pressure-based cardiac output estimation methods. The issue of a less-adequate performance of 
those methods in patients showing a decreased systemic vascular resistance is also problematic in 
intensive care patients (14). Furthermore, low and high systemic vascular resistance leads to the 
under- or overestimation of cardiac output as estimated by impedance cardiography, respectively 
(15). The impedance cardiography data that were tracked in parabolic flight and presented in 
chapter two agree with this statement as they underestimate cardiac output in microgravity when 
total peripheral resistance is low with respect to inert gas rebreathing.  
In conclusion, the evaluation of cardiac output estimation methods based on impedance 
cardiography and arterial pulse pressure in healthy parabolic flight subjects shows similar 
limitations of the methods with respect to their application in critically ill patients. Therefore, it 
seems useful to supplement the mandatory feasibility studies of these techniques in critically ill 
patients with studies in parabolic flight to test these methods over the maximal range of cardiac 
performance and without the ethical issues of performing research in patients lacking consent 
capacity. Furthermore, because of the very rapid cardiovascular changes in parabolic flight, this 
setup is predestinated to test the trending capability of those methods. 
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5.2 Behavior of cardiac output as the key variable of the circulation during intense 
orthostatic and anti-orthostatic stress in parabolic flight 
Cardiac output is one of the key variables of circulation and serves therefore as a global indicator 
of the level of operation of the circulation. Cardiac output describes the total blood flow that is 
generated by the heart, which, in normal adults at rest, is 5 L/min on average and ranges from 4.0 
to 6.5 L/min (16). At this point, it is noticeable that the mean cardiac output of the patients of the 
study of Sun et al. as cited above was approximately 5 L/min, which indicates circulation not being 
under maximal stress. Without nerve excitation, a normal heart can increase its pumping capability 
up to 13 L/min if it receives the appropriate amount of venous return (17). Under the influence of 
sympathetic stimulation and vagal inhibition, which leads to increased contractility and tachycardia, 
the normal heart can pump up to 25 L/min (17). However, the heart itself does not control the 
amount of blood that it pumps but the venous return. The heart simply pumps the blood that 
returns to it. The Frank Starling mechanism guarantees that the heart can adapt to increased 
amounts of blood flowing into its chambers. The venous return on the other hand is the sum of all 
of the local blood that flows through all of the particular tissue compartments of the peripheral 
circulation (17). Indeed, this pattern is not the case in parabolic flight. The results of chapters two 
and four show that cardiac output increases up to 16 L/min in microgravity in healthy subjects 
undergoing a parabolic flight maneuver in a standing position, which is approximately the cardiac 
output observed in healthy subjects performing dynamic exercise (18). However, this pattern is not 
the case because peripheral tissues demand this cardiac output in parabolic flight, because this 
maneuver requires only moderate static exercise from the subject, and because the disappearance 
of the hydrostatic column lasting on the venous system leads to a prompt increase in venous return 
coupled with a still sympathetically activated heart. The sympathetic activation of the heart arises 
from the increased orthostatic stress in the preceding hypergravity phase. Thus, the short 
microgravity phase of a parabolic flight maneuver provokes a hyperperfusion of the circulation, 
which is fortunately immediately limited by the regulatory reflex responses of circulation.  
During hypergravity, cardiac output decreases with respect to 1 Gz but not with the same 
magnitude as it increases during microgravity. This result is understandable because most of the 
blood volume, approximately 500 ml, shifts from the central to the dependent compartments after 
standing up in 1 Gz. Increasing Gz causes only an additional 12-50 ml/Gz of blood pooling in the 
legs, which takes only 25 sec (19). This result means that for the parabolic flight maneuver, in the 
brief 1.8 Gz hypergravity phase, less than 100 ml of additional blood is shifted to the legs with 
respect to 1 Gz.  
In clinical medicine, circulatory hyperperfusion syndromes due to low total peripheral resistance 
are observed in patients with liver cirrhosis (20) and in patients suffering from an insufficient 
quantity of thiamine in the diet (Beriberi disease) (17). Furthermore, a hyperdynamic circulatory 
state can be triggered by cytokines, such as Il-2 and TNF-alpha, which lead to a systemic 
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inflammatory response syndrome (21). However, cardiac outputs of greater than 12 L/min are 
seldom observed in anesthesiology and intensive care medicine.  
5.3 Response of the pulmonary circulation to orthostatic and anti-orthostatic stress in a 
moderately hypobaric hypoxic environment 
The cabin of a commercial airplane, such as the A300 Zero-G, exposes subjects and passengers 
to a moderately hypobaric hypoxic atmosphere during flight. The impact of this particular 
atmosphere on the pulmonary gas exchange of individuals has been of great interest even for the 
anesthesiologist. In 2005, Humphreys and colleagues published an article on the effect of high-
altitude commercial air travel on oxygen saturation in Anaesthesia (22). These authors found a 
significant reduction in oxygen saturation in their 84 subjects during flight with respect to ground 
control. Smith et al. investigated pulmonary arterial pressure during commercial air travel in healthy 
passengers with respect to their ground controls and found a significant increase in systolic 
pulmonary arterial pressure in flight, even though the average arterial oxygen saturation only 
decreased from 98 to 95%. This result agrees with the decreased oxygen saturation that is 
observed in the subjects of this thesis both in flight and in the hypobaric chamber and is 
reproducible by the simple physiological model that is shown in fig. 5.1. By applying the model of 
fig. 5.1, one obtains an arterial partial oxygen pressure of approximately 67 mmHg for a subject 
during his sojourn in the A300 Zero-G cabin. Furthermore, the rebreathings in the hypobaric 
chamber at A300 Zero-G cabin atmosphere equivalent indicate a reduced pulmonary tissue 
volume, confirming that hypoxic pulmonary vasoconstriction already exists at this relatively high 
predicted arterial partial oxygen pressure. This result could be surprising regarding Cutaia’s and 
Rounds’s report of 60-mmHg partial oxygen pressure as threshold for the hypoxic pulmonary 
vasoconstriction (26). However, the data of Humphreys and Smith and the results of this thesis 
suggest that the oxygen pressure threshold above which no hypoxic pulmonary vasoconstriction 
appears must be higher than 60 mmHg, which fully agrees with the review of Sylvester and 
colleagues, who found 83 mmHg of partial oxygen pressure as the threshold for hypoxic pulmonary 
vasoconstriction (27). 
The value of 83 mmHg partial oxygen pressure as threshold for hypoxic pulmonary 
vasoconstriction might be interesting for the anesthesiologist when considering the best inspiratory 
oxygen fraction during thoracic anesthesia. Furthermore, it might be interesting in the rare cases of 
providing anesthesia in patients with Fontan circulation undergoing non-cardiac surgery. In these 
patients, keeping pulmonary resistance down is of eminent importance for the filing of their single 
ventricle (28).  
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Figure 5.1: Red rhombs show the predicted arterial oxygen saturation (SO2) inflight inside the cabin of the 
A300 Zero-G based on the model atmosphere of J. West (23). The x-axis shows the altitude that is 
equivalent to the cabin pressure. The blue graph shows SO2 in a subject who does not hyperventilate due to 
the hypobaric hypoxic environment, whereas the black graph shows SO2 in a hypoxia-adapted subject with 
hyperventilation. The dashed black graph provides the barometric pressure with respect to altitude. The 
green graph represents the ambient partial oxygen pressure, and the blue dashed graph provides the 
alveolar oxygen partial pressure that was calculated via the classical alveolar gas formula (24). An oxygen 
partial pressure difference of 5 mmHg is assumed between the alveolar space and the pulmonary capillaries 
due to a small physiological ventilation/perfusion inequality (25). 
A further important aspect of this thesis regarding pulmonary circulation is the fact that the 
pulmonary tissue volume decreased in hypobaric hypoxia but increased in hypobaric hypoxia 
coupled with microgravity or hypergravity. Assuming the absence of any interstitial edema 
formation during the measurements, let changes in lung tissue volume solely depend on changes 
in pulmonary capillary blood volume. Although Snyder et al. showed a reduced lung tissue volume 
in moderate hypoxia (29) and Rohdin and Linnarsson showed an increased lung tissue volume in 
hypergravity (30) and estimated an increased lung tissue volume in microgravity based on the 
parabolic flight data of Vaida et al. (31), this thesis shows for the first time in the same subject that 
the reduction in pulmonary blood volume in hypobaric hypoxia is reversed by a central blood 
volume shift in weightlessness and by the sequestration of blood in the dependent parts of the lung 
circulation in the hypergravity phases. From a clinical standpoint, these observations lead to the 
conclusion that hypoxic pulmonary vasoconstriction is affected by the cardiac output and the 
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thoracic blood volume. Thus, an anesthesiologist should consider these two variables when trying 
to influence the hypoxic pulmonary vasoconstriction during anesthesia.  
5.4 How the human body fluid and endocrine systems respond to a combination of 
moderate hypobaric hypoxia and gravity changes 
The human body fluid regulation system is simultaneously exposed to three stresses in parabolic 
flight: first, the aridity of the airplane cabin atmosphere; second, hypobaric hypoxia; and third, 
changing orthostatic loads. All of these stresses are expected to decrease the plasma volume, but 
their simultaneous impacts on the human body have not been well investigated prior to this thesis. 
However, the plasma volume showed only similar and moderate changes in parabolic flight and in 
the hypobaric chamber in the range of ±100 ml. This result is not surprising because an adequate 
plasma volume is crucial for an adequate filling of the heart and thus for an adequate cardiac 
performance. It is therefore natural that the human body does everything in its power to preserve 
intravascular volume. Body fluid changes in the magnitude of only 100 ml have also previously 
been reported from tests in hypobaric chambers operating at an altitude equivalent of 2000 a. m. s. 
l. (32) and in zero-humidity environments (33). Thus the work of this thesis shows again the 
stability of the human plasma volume despite significant environmental stress. From a hormonal 
standpoint, this thesis confirms the well-known fact that hypoxia induces a negative fluid status, 
whereas orthostatic stress triggers the storage of fluids as observed from increased aldosterone 
values in the hypobaric chamber and decreased aldosterone values in parabolic flight. However, it 
is remarkable that renin did not show a parallel response with aldosterone in parabolic flight, 
suggesting a dissociation of the aldosterone level and renin response under the conditions of 
parabolic flight. Interestingly, dissociation of plasma aldosterone levels and plasma renin activity 
has previously been reported in subjects experiencing presyncope and in subjects undergoing 
repeated orthostatic challenges (34, 35).  
NT-proBNP, which is involved in the fluid homeostasis of the human body and is therefore of 
interest for the anesthesiologist, showed two remarkable behavior patterns with importance for 
clinical medicine within the framework of this thesis. First, the baseline value of NT-proBNP was 
significantly higher in female than in male subjects. Higher basic values in women have been 
previously reported (36) and should be considered for the interpretation of borderline values of NT-
proBNP. Second, NT-proBNP increased in parabolic flight, most likely due to the central blood 
volume shift in microgravity; this did not occur during head-down tilt but during volume loading in 
the study of Heringlake and others (37). 
5.5 Outlook 
The subject population of this thesis contained an equal number of both genders, and thus a 
gender analysis regarding differences in hormonal and cardiovascular responses to parabolic 
orthostatic stress coupled with moderate hypobaric hypoxia would be reasonable and should be 
the scope of a future analysis of the datasets.  
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The behavior of hypoxic pulmonary vasoconstriction under orthostatic stress should be further 
examined by increasing hypoxia by the rebreathing of hypoxic gas mixtures via a face mask during 
parabolic flights.  
The method of non-invasive cardiovascular index estimation via pulse curve analysis should be 
improved, especially in circulatory states with low total peripheral resistance in microgravity.  
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Summary  
In this thesis, the estimation of circulatory indices was performed non-invasively from several bio-
signals in healthy subjects whose cardiovascular system was in a non-steady state due to rapid 
gravity transitions that were created by parabolic flight maneuvers. Furthermore, the interactions of 
the cardiopulmonary, the hormonal and the body fluid systems in parabolic flight were investigated.  
Chapter one provides a detailed introduction to gravitational physiology in general and to 
cardiovascular physiology in parabolic flight in particular. Great scientific overlap of the fields of 
extreme environmental physiology and anesthesiology is demonstrated based on the relevant 
clinical and physiological literature. Furthermore, the scientific methods and facilities that were 
used in this thesis are discussed in detail. 
Chapter two describes the primary study of this thesis in which beat-to-beat cardiac output 
estimation in parabolic flight by thoracic impedance and finger blood pressure analysis were 
compared to the non-invasive gold standard of absolute cardiac output determination, namely the 
test gas re-breathing method. The compatibility of the methods was determined by the Bland and 
Altman analysis. The absolute cardiac output was determined for the first time by re-breathing 
during transition from hypergravity to microgravity in standing subjects.  
Chapter three describes a more advanced comparative analysis of cardiac index estimation by ten 
pulse curve methods that were applied during gravity transitions. The results of the pulse curve 
analyses were compared to the results of the cardiac output data that were simultaneously 
collected by inert gas re-breathing.  
Chapter four describes the final physiological experiment that was based on the two former studies 
and that investigated the physiology of the human cardiovascular system during gravity transitions 
in parabolic flight in great detail. Emphasis was placed on the body fluid regulation system, the 
hormonal system and the pulmonary circulation. The effects of the hypobaric hypoxic atmosphere 
of the airplane cabin were emphasized in particular. 
Chapter five presents the results of the thesis within a physiological and clinical context. It is 
demonstrated that the methods of cardiovascular index estimation based on pulse curve analysis 
and impedance cardiography have similar methodical limitations in the intensive care setting and in 
parabolic flight. It is furthermore illustrated that cardiac output after transition in microgravity in 
parabolic flight is higher than that required by the peripheral tissues and that the pulmonary 
vasculature and the human body fluid system underlie a nested physiological regulation as 
influenced by multiple environmental factors. 
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Zusammenfassung 
Im Rahmen dieser Doktorarbeit wurden Parameter des Herzkreislaufsystems gesunder Probanden 
aus verschiedenen Biosignalen berechnet. Die Messungen wurden in den 
Schwerkraftsübergängen von Parabelflügen durchgeführt, während sich das Herzkreislaufsystem 
in keinem Gleichgewichtszustand befand. Außerdem wurden Interaktionen von kardiopulmonalem 
und hormonellem System und der Flüssigkeitshomöostase im Parabelflug untersucht. 
Kapitel eins gibt eine detaillierte Einleitung in die Gravitationsphysiologie und in die 
Herzkreislaufphysiologie auf Parabelflügen. Wissenschaftliche Überschneidungen von Physiologie 
unter extremen Umweltbedingungen und Anästhesiologie werden anhand klinischer und 
physiologischer Literatur aufgezeigt. Die wissenschaftlichen Methoden und Versuchseinrichtungen, 
die dieser Doktorarbeit zugrunde liegen, werden im Detail beschrieben. 
Kapitel zwei beschreibt das erste Experiment dieser Doktorarbeit im Rahmen dessen das 
Herzzeitvolumen kontinuierlich mittels Thoraximpedanzmethode und Fingerblutdruckanalyse auf 
Parabelflügen untersucht und mit dem nichtinvasiven Goldstandard der absoluten 
Herzzeitvolumenbestimmung, der Testgasrückatmung, verglichen wurde. Die Vergleichbarkeit der 
Methoden wurde mittels Bland und Altman Analyse bestimmt. Das absolute Herzzeitvolumen der 
stehenden Probanden wurde zum ersten Mal mittels der Rückatemmethode während des 
Übergangs von Hypergravitation in Mikrogravitation bestimmt. 
Kapitel drei beschreibt den Vergleich der Berechnung des Herzzeitvolumens auf der Grundlage 
von zehn verschiedenen Pulskontourmethoden während Schwerkraftsübergängen. Das 
Herzzeitvolumen der verschiedenen Pulskontourmethoden wurde mit dem gleichzeitig mittels 
Testgasrückatmung bestimmten Herzzeitvolumen verglichen.  
Kapitel vier stellt das abschließende physiologische Experiment der Arbeit dar, welches auf den 
Resultaten der Kapitel zwei und drei basiert. Dieses hatte die detaillierte Untersuchung des 
menschlichen Herzkreislaufsystems während Schwerkraftsübergängen im Parabelflug zum Ziel. 
Besonderes Gewicht wurde dabei auf die hormonelle Regulation des Wasserhaushalts und auf die 
Lungenzirkulation gelegt. Die Auswirkungen des verminderten Luftdrucks und des verminderten 
Sauerstoffpartialdrucks der Flugzeugkabine wurden berücksichtigt. 
Im fünften Kapitel werden die Ergebnisse dieser Arbeit in den klinischen und physiologischen 
Kontext eingeordnet. Dabei wird klar, dass die Pulskontourmethoden und die 
impedanzkardiographischen Methoden der kardiovaskulären Indexberechnung ähnliche 
methodische Limitationen in der Weltraummedizin wie auf einer Intensivstation haben. Außerdem 
wird klar, dass das Herzzeitvolumen in der Mikrogravitation eines Parabelflugs höher ist, als in 
dieser Situation vom Körper benötigt und dass die Lungenzirkulation und die 
Flüssigkeitshomöostase verschachtelten Regulationsmechanismen unterliegen, die von einer 
Vielzahl der Umweltfaktoren eines Parabelflugs beeinflusst werden. 
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Abbreviations 
a. m. s. l. above mean sea level 
ATP  ambient temperature and pressure 
AVP  arginine vasopressin 
BCG  bromocresol green 
BTPS  body temperature and pressure, saturated 
CI  cardiac index 
CIrb  cardiac index by rebreathing 
CNES  Centre national d’études spatiales 
CO  cardiac output 
COHB  carboxyhemoglobin 
CORB  optimized carbon monoxide rebreathing method 
COrb  cardiac output by rebreathing 
CVP  central venous pressure 
DLR  Deutsches Zentrum für Luft- und Raumfahrt (German Aerospace Center) 
DRA  direct renin activity 
ECG  electrocardiogram 
EDTA  ethylenediaminetetraacetic acid 
ELISA  enzyme-linked immunosorbent assay 
FBP  finger blood pressure 
FBPdiast diastolic finger blood pressure 
FBPsyst  systolic finger blood pressure 
FiO2  inspiratory oxygen fraction 
Gx  acceleration along the sagittal axis 
Gy  acceleration along the frontal axis 
Gz  acceleration along the head to toe axis 
HR  heart rate 
ICG  impedance cardiography 
ISS  International Space Station 
JAR  Joint Aviation Requirements 
LVET  left ventricular ejection time 
MAP  mean arterial pressure 
PBF  pulmonary blood flow 
pACO2  alveolar partial pressure of carbon dioxide 
pAO2  alveolar partial pressure of oxygen 
pH2O  partial pressure of water vapor 
POI  postflight orthostatic intolerance 
pO2  partial pressure of oxygen 
PV  plasma volume 
RQ  respiratory quotient 
SI  stroke index 
SO2  arterial oxygen saturation 
SIrb  stroke index by rebreathing 
SV  stroke volume 
SVrb  stroke volume by rebreathing 
tHb  total hemoglobin mass 
VO2  alveolar oxygen consumption 
Vt  volume of pulmonary tissue  
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